BioNTech to invest $43 million in new mRNA facility
BioNTech SE, an immunotherapy company, will invest $43 million in a new facility in Germany to make a vital ingredient for its mRNA.
Drugs
Pharma
Medical
Pharma
BioNTech signs MoU with UK govt to start clinical trials for mRNA cancer vaccine
BioNTech signs MoU with the British government to start mRNA cancer trials
Drugs
Pharma
Aurobindo Pharma gets FDA nod for injection to treat cancer
Aurobindo Pharma announced that its fully-owned subsidiary, Eugia Pharma Specialities, received final approval from FDA to make and market Azacitidine injection for cancer.
Drugs
Pharma
Israeli researchers develop artificially intelligent pathological assistants
Israeli researchers have succeeded in making computers into pathological assistants at a time when healthcare companies are trying to overcome a global shortage.
Drugs
Health
Popular variant of Vitamin B3 may cause cancer, finds study
Some vitamins can have fatal side-effects as a new study finds that Niacin may carry risk of brain cancer
Drugs
Health
Medical
WHO says 3.5 billion people globally have oral diseases
About 45% of the world’s population, or 3.5 billion people, are suffering from oral diseases, a new study states.
Drugs
Pharma
EMA cracks the whip on JAK inhibitors for inflammatory disorders
The European Medicines Agency has suggested steps to minimize the risk of severe side effects associated with Janus kinase (JAK) inhibitors, used to.
Drugs
Pharma
Aurobindo to recall two drugs with potential cancer risk
HQ Team October 26, 2022: Aurobindo Pharma US has initiated a voluntary recall of two lots of tablets in the American market due to the.
Drugs
Pharma
Canada recalls Unilever’s dry shampoo products over cancer concern
HQ Team October 21, 2022: Canada has recalled more than a million units of dry shampoo products of London-based Unilever after detecting a.